{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:17Z","timestamp":1792784117843,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Spero Therapeutics, Cambridge, MA"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jgar.2020.10.020","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T11:49:59Z","timestamp":1605527399000},"page":"439-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Resistance among urinary tract pathogens collected in Europe during 2018"],"prefix":"10.1016","volume":"23","author":[{"given":"Ian A","family":"Critchley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cotroneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo E.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.10.020_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-777X.138515","article-title":"Comparison of etiological agents and resistance patterns of the pathogens causing community acquired and hospital acquired urinary tract infections","volume":"6","author":"Ahmed","year":"2014","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.jgar.2020.10.020_bib0010","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1093\/ofid\/ofz004","article-title":"Application of Next-Generation Sequencing for characterization of surveillance and clinical trial isolates: analysis of the distribution of \u03b2-lactamase resistance genes and lineage background in the United States","volume":"6","author":"Mendes","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2020.10.020_bib0015","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00404-019-05256-z","article-title":"Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance-non-antibiotic approaches: a systemic review","volume":"300","author":"Wawrysiuk","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jgar.2020.10.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020251","article-title":"Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study","volume":"8","author":"Vallejo-Torres","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jgar.2020.10.020_bib0025","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/AAC.02961-15","article-title":"Susceptibility of Multidrug-resistant Gram-negative urine isolates to oral antibiotics","volume":"60","author":"Hirsch","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.10.020_bib0030","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","article-title":"The CTX-M \u03b2-lactamase pandemic","volume":"9","author":"Canton","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jgar.2020.10.020_bib0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/CMR.00116-14","article-title":"The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae","volume":"28","author":"Mathers","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2020.10.020_bib0040","article-title":"Overview of ESBL-producing Enterobacteriaceae from a nordic perspective","volume":"4","author":"Brolund","year":"2014","journal-title":"Infect Ecol Epidemiol"},{"key":"10.1016\/j.jgar.2020.10.020_bib0045","series-title":"Annual report of the european antimicrobial resistance surveillance network (EARS-Net)","year":"2014"},{"key":"10.1016\/j.jgar.2020.10.020_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220265","article-title":"The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017","volume":"14","author":"Critchley","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2020.10.020_bib0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1002003123629","article-title":"Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997","volume":"77","author":"Fluit","year":"2000","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.jgar.2020.10.020_bib0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2020.10.020_bib0065","doi-asserted-by":"crossref","DOI":"10.3201\/eid2209.160148","article-title":"Fluoroquinolone-resistant and extended-spectrum \u03b2-lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States(1)","volume":"22","author":"Talan","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2020.10.020_bib0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/cid\/ciu864","article-title":"Emerging Escherichia coli O25b\/ST131 clone predicts treatment failure in urinary tract infections","volume":"60","author":"Can","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.10.020_bib0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1120009X.2017.1380397","article-title":"Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections","volume":"29","author":"Concia","year":"2017","journal-title":"J Chemother"},{"key":"10.1016\/j.jgar.2020.10.020_bib0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3904\/kjim.2011.26.1.89","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum \u03b2-lactamase production in Proteus mirabilis bacteremia","volume":"26","author":"Sohn","year":"2011","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jgar.2020.10.020_bib0085","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw281","article-title":"The increase in hospitalizations for urinary tract infections and the associated costs in the United States, 1998-2011","volume":"4","author":"Simmering","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2020.10.020_bib0090","article-title":"Oral amoxicillin-clavulanic acid treatment in urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing organisms","volume":"8","author":"Beytur","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.jgar.2020.10.020_bib0095","doi-asserted-by":"crossref","first-page":"e02618","DOI":"10.1128\/AAC.02618-18","article-title":"Antimicrobial activity evaluation of tebipenem (SPR859), an orally available carbapenem, against a global set of Enterobacteriaceae isolates, including a challenge set of organisms","volume":"63","author":"Arends","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.10.020_bib0100","doi-asserted-by":"crossref","first-page":"e00618","DOI":"10.1128\/AAC.00618-19","article-title":"Safety, Pharmacokinetics, and food effect of tebipenem pivoxil hydrobromide after single and multiple ascending oral doses in healthy adult subjects","volume":"63","author":"Eckburg","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:54:44Z","timestamp":1761990884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520302836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":20,"alternative-id":["S2213716520302836"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.10.020","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance among urinary tract pathogens collected in Europe during 2018","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}